Continuous Blood Glucose Monitors: How CGMs Work, Who They Help, and What to Ask

A continuous glucose monitor (CGM) is a wearable sensor that estimates glucose in the fluid just under your skin and sends repeated readings and trends to a phone or reader. It is most useful for many people with diabetes, especially those using insulin or at risk of low blood sugar, while its value for people without diabetes is less clear.1

What is a continuous blood glucose monitor?

A CGM is a small sensor worn on the body that estimates glucose repeatedly throughout the day and night. The term “continuous blood glucose monitor” is common, but the sensor actually measures glucose in interstitial fluid, the fluid between cells, rather than capillary blood from a fingerstick.2

A traditional blood glucose meter, also called self-monitoring blood glucose or fingerstick glucose testing, gives one capillary blood glucose result at that moment. A CGM adds context: current estimated glucose, direction of change, and a record of patterns that can be reviewed with a clinician.1

What a CGM measures

CGMs estimate interstitial fluid glucose. Because glucose moves between blood and interstitial fluid, the two readings can differ briefly, especially during fast changes after food, exercise, insulin, or treatment for hypoglycemia.2

How often readings update

Update frequency depends on the specific system. What matters most is that CGMs provide repeated data and trend information, which can show patterns that occasional fingersticks may miss.1

How long sensors usually last

Sensor wear time varies by device and model. Check the manufacturer’s current instructions for the specific FreeStyle Libre, Dexcom, Medtronic Guardian, or other CGM you are considering, because approved wear time and placement can differ.

When fingerstick checks may still be needed

A fingerstick may be important when symptoms do not match the CGM, when a result seems unexpected, or when device instructions say confirmation is needed. Interstitial glucose lag is a key reason to take a mismatch seriously.2

How does a CGM work?

A CGM sensor sits just under the skin and detects glucose in interstitial fluid. The device sends that estimate to a reader, phone app, or—in some systems—an insulin delivery system.2

Some CGM systems can work with automated insulin technology. In randomized trials of hybrid closed-loop control, which combines CGM data with automated insulin delivery, investigators found improved glucose-management outcomes in people with type 1 diabetes, including young children.3 4 These findings are specific to the studied systems and populations; device use can still involve burdens such as alerts, skin irritation, and the need for ongoing training and clinical support.1

How is a CGM different from a fingerstick glucose meter?

The main difference is trend data versus a single result. A meter measures capillary blood glucose at one time; a CGM estimates interstitial glucose repeatedly and may show whether levels are stable, rising, or falling.1

Interstitial fluid lag and why it matters

When glucose is rising or falling quickly, interstitial fluid values may trail capillary blood glucose. That is why a number on a screen should be considered alongside symptoms, trend arrows, device directions, and a clinician’s plan.2

Alerts, alarms, and trend arrows

Many CGMs can alert the user to a possible high or low glucose level. Alerts may help some people notice hypoglycemia sooner, but frequent notifications can also create stress or alarm fatigue.1

Who is most likely to benefit from a CGM?

CGMs have the strongest evidence base in type 1 diabetes and in people with type 2 diabetes who use insulin. The value of CGM depends on medication use, hypoglycemia risk, ability to use the data, access, and support from a diabetes care team.1

• People with type 1 diabetes, including people using pump or hybrid closed-loop insulin delivery systems.3
• People with type 2 diabetes who use insulin or have recurring hypoglycemia concerns.1
• People whose clinician needs more information about possible glucose patterns, such as overnight changes or unexplained symptoms.
• People with prediabetes or no diabetes only when there is a clear question to answer; current evidence does not show that consumer CGM use alone improves health outcomes for everyone without diabetes.1

For people with prediabetes or type 2 diabetes, food pattern and activity changes can affect glucose outcomes. A randomized crossover trial compared ketogenic and Mediterranean-style eating patterns in adults with prediabetes or type 2 diabetes, and another randomized crossover trial found different glucose responses to morning versus afternoon exercise in its study group.5 6 A CGM may show patterns, but it does not tell you which diet or exercise plan is right for you.

What are the main benefits and limits of CGMs?

A CGM may help a person and their clinician look beyond one glucose value to time in range, A1C, and hypoglycemia patterns. Reviews of diabetes monitoring studies report that effects on A1C vary by device and population, with much of the evidence concentrated in type 1 diabetes.1

CGM data can be useful for noticing possible connections among meals, activity, sleep, illness, and medication timing. But a graph cannot explain every rise or fall, and reacting to every small change can lead to unnecessary food restriction, anxiety, or medication mistakes.1

Can you shower, swim, or exercise with a CGM?

Many CGM systems are designed for normal daily activities, but water exposure, swimming limits, exercise, sensor placement, and adhesive care are device-specific. Always use the manufacturer’s current instructions for your exact device rather than assuming that guidance applies across CGMs.

Exercise can change glucose needs and readings, especially for people using insulin. If activity causes repeated lows, highs, or confusing sensor data, discuss the pattern with the clinician who manages your diabetes treatment.6

How much does a CGM cost, and can you get one without insurance?

CGM cost depends on the device, sensor replacement schedule, pharmacy price, prescription status, insurance coverage, and local rules. There is no single cheapest CGM that fits everyone, so compare the total ongoing sensor cost—not only the first reader or starter price.

Some CGMs are prescription products and some consumer-oriented over-the-counter CGM options may be available depending on location and product status. Medicare, commercial insurance, and NHS-style coverage rules are separate systems and can change; ask the device maker, pharmacy, insurer, or prescribing clinician about current eligibility and out-of-pocket costs.

How should CGM data be used safely?

Use CGM data as one part of a care plan, not as a reason to make unplanned medication changes. A surprising reading deserves context: consider symptoms, trend direction, food, activity, and whether your device instructions call for a fingerstick confirmation.2

Seek urgent medical help for symptoms or readings suggesting severe hypoglycemia, severe hyperglycemia, diabetic ketoacidosis, or any emergency. Symptoms such as confusion, fainting, seizure, trouble breathing, persistent vomiting, or severe weakness need urgent attention regardless of what a device screen shows.1

How can blood sugar trends fit into weight care at Chia?

CGM trends can sometimes give a clinician useful context about eating patterns, glucose changes, and medication questions. They do not diagnose insulin resistance or determine whether a person needs weight-loss medication; that requires a full clinical review.

At Chia, eligible adults can be evaluated online for semaglutide or tirzepatide. Semaglutide and tirzepatide are distinct active ingredients; brand names such as Wegovy and Zepbound refer to specific FDA-approved products and should not be treated as equivalent to compounded formulations.

Chia offers semaglutide as an injection, with provider-guided dosing and microdosing plans available where clinically appropriate. Tirzepatide is available as tablets or injections, also with provider-guided dosing and microdosing plans where clinically appropriate. Compounded medications are not FDA-approved. Our providers review a health questionnaire online, prescribe only when clinically appropriate, and patients can message their care team through the portal between visits.

If prescribed, medications are compounded in the United States by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Compounded medications are not FDA-approved, and outcomes are not established for compounded formulations. Our providers can also help patients interpret whether glucose-monitoring information belongs in a broader metabolic-care conversation.

What should you ask your clinician before starting a CGM?

Before starting a CGM, ask what question the device is meant to answer and what you should do with a high, low, or unexpected result. The best monitoring plan is personal and should account for your diagnosis, medicines, hypoglycemia risk, skin sensitivity, budget, and ability to respond to alerts.1

• Do I need a personal CGM, a short-term professional CGM, or a standard glucose meter?
• When should I confirm a CGM result with a fingerstick?
• What alerts should I use, and what symptoms mean I need urgent help?
• Will my medications, supplements, skin products, or activity affect the device or its interpretation?
• What will insurance cover, and what will sensors cost over time?
• How should I share data with my diabetes or primary-care clinician?

For more background, see our guides to blood sugar monitoring systems, diabetes blood glucose meters, and normal blood sugar levels.

FAQ

Keep reading

Metabolic Health

Diabetes Blood Glucose Machines: How to Choose a Meter or CGM

Metabolic Health

Blood Sugar Test Kits: How to Choose and Use One at Home

Metabolic Health

Non-Invasive Blood Glucose Monitors: What Works, What Is Still Experimental, and What to Use Now